Navigation Links
NYU and NYU Langone researchers devise method for enhancing CEST MRI
Date:4/29/2013

Researchers at New York University and NYU Langone Medical Center have created a novel way to enhance MRI by reducing interference from large macromolecules that can often obscure images generated by current chemical exchange saturation transfer (CEST) methods.

Their work, which appears in the Nature publishing group journal Scientific Reports, has the potential to improve MRI for cartilage as well as for brain tissue.

"We have found a way to eliminate signals of certain molecules and thereby clean up the image of parts of the body that could be used by medical professionals in order to make diagnoses," explained Alexej Jerschow, a professor in NYU's Department of Chemistry.

The study's other authors were: Ravinder Regatte, professor, Departments of Radiology and Orthopedic Surgery, NYU Langone Medical Center; Prodromos Parasoglou, a post-doctoral research fellow, and Ding Xia, an assistant research scientist, at the Center for Biomedical Imaging, Department of Radiology at NYU Langone Medical Center; and Jae-Seung Lee, an NIH research fellow, who holds appointments in NYU's Department of Chemistry and NYU Langone Medical Center.

The researchers' work aims to improve a decade-old method, chemical exchange, which has been used to enhance MRI techniques. Under this approach, scientists exploit the movement of atoms from their natural molecular structure to water in the body in order to enhance their visibility.

However, these efforts have often been hindered by the presence of macromolecules, which continue to obscure the smaller molecules that are of interest to doctors and other health-care professionals in making assessments. The macromolecules' interference is the result of two phenomena: their size and their frequencies.

Neutralizing the macro-molecular frequency interference was the focus of the NYU method reported in Scientific Reports recently.

Previously, Jerschow, Regatte, and colleagues created a non-invasive imaging technique for glycosaminogycans (GAGs), which are molecules that serve as the building blocks of cartilage and are involved in numerous vital functions in the human body. Here, under chemical exchange, they separated out the GAG protons from those of water, creating an inherent contrast agent. Testing the idea in tissue samples, the researchers found that the available GAG protons provided an effective type of contrast enhancement, allowing them to readily monitor GAGs through a clinical MRI scanner.

In the Scientific Reports work, the researchers again focused on improving visibility of GAGs through MRI. But, in this effort, they sought to block the signaling impact of the macromolecules that obscure the observation of GAGs.

To do so, they took advantage of macromolecules' broad frequency spectruma trait that allows for easy detection and neutralization. Specifically, the researchers could, in effect, "bleach" the signal out by simultaneously using multiple irradiation frequencies. As a result, macromolecular interference diminished and enhanced the quantitative assessment of GAGs.

"This method gives us the opportunity to correct existing CEST methods by focusing on molecular signals of interest with much better precision than currently exists," explains Regatte.


'/>"/>

Contact: James Devitt
james.devitt@nyu.edu
212-998-6808
New York University
Source:Eurekalert

Related medicine news :

1. NYU Langone experts present research, clinical advances at neurosurgeons meeting
2. NYU Langone Medical Center receives $17 million gift from the Steven A. and Alexandra M. Cohen Foundation
3. NIH awards $20 million over 5 years to train next generation of global health researchers
4. Researchers develop a new cell and animal model of inflammatory breast cancer
5. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
6. Researchers Find Gene Mutations That May Be a Key to Autism
7. Researchers find evidence of banned antibiotics in poultry products
8. NJ stroke researchers report advances in spatial neglect research at AAN Conference
9. Autism by the numbers: Yale researchers examine impact of new diagnostic criteria
10. Researchers Map Brain Regions Linked to Intelligence
11. Researchers ID Genes That May Determine Mental Illness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: